Myomo Announces Second Quarter 2018 Financial Results
CAMBRIDGE, Mass., August 7, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the second quarter ended June 30, 2018. Read more.
Myomo Reports Second Quarter 2018 Results
CAMBRIDGE, Mass., July 31, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that it will release its financial results for the second quarter 2018 on Tuesday, August 7, 2018, after the US markets close. Read more.
Myomo Appoints Micah Mitchell as Chief Commercial Officer
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, announced today that Micah Mitchell is joining the company as chief commercial officer (CCO), a newly created executive role. The addition of a CCO reflects Myomo’s transition from a controlled introduction of its proprietary MyoPro product line to expansion of […]
Research Team Presents Promising Preliminary Results from TBI Study Using Myomo’s MyoPro
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Researchers from the Northwestern University Prosthetics-Orthotics Center (NUPOC) and the Cleveland VA Medical Center have presented promising preliminary case reports from a clinical trial that evaluates the effects of the MyoPro myoelectric arm orthosis (powered brace) from Myomo on traumatic brain injury (TBI) patients at the Cleveland VA Medical Center. Read more.
Myomo Brings Myopro Adolescent Patients
CAMBRIDGE, Mass., June, 6, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that its MyoPro myoelectric arm orthosis (powered brace) is now available to adolescent patients with paralyzed or weakened arms. MyoPro is the only lightweight wearable device on the market that can help restore […]
Myomo Announces MyoPro Availability in 16 New U.S. Locations
CAMBRIDGE, Mass., May 24, 2018 – Myomo®, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced agreements with leading orthotics and prosthetics practices to bring MyoPro® availability to 16 new U.S. locations. Read more.
Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision
CAMBRIDGE, Mass., May 14, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo,” or the “Company”), a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services (“CMS”) has published a favorable preliminary decision regarding the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December […]
Myomo, Inc. Issues May 2018 Shareholder Letter
CAMBRIDGE, Mass., May 10, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today issued a letter to shareholders to give an update on first quarter 2018 and ongoing MyoPro® commercial activities. Read more.
Myomo Reports First Quarter 2018 Results
CAMBRIDGE, Mass., May 9, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the first quarter ended March 31, 2018. Read more.
Myomo Announces Free Screening Days in Over 20 Cities Nationwide
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, announces a nationwide program of free screening days to be held in collaboration with its Centers of Excellence, other orthotics and prosthetics practices and its rehabilitation therapy partners. Read more.